Article
type: Class

Document
type: Class

Anualidad
type: Class

Academic Article
type: Class

Information Content Entity
type: Class

Continuant
type: Class

Entity
type: Class

2023
type: Class

Generically Dependent Continuant
type: Class

individual
type: Document
rights: termsOfUse
date: 2026-08-31T18:34:09
publisher: Comparative effects of glucagon-like peptide-1 receptors agonists, 4-dipeptidyl peptidase inhibitors, and metformin on metabolic syndrome
label: RDF description of Comparative effects of glucagon-like peptide-1 receptors agonists, 4-dipeptidyl peptidase inhibitors, and metformin on metabolic syndrome - http://research.umh.es/vivo/pub/articulo/258803

Comparative effects of glucagon-like peptide-1 receptors agonists, 4-dipeptidyl peptidase inhibitors, and metformin on metabolic syndrome
type: Document
related by: AutorExt:404028_2023-Artículo:258803
related by: AutorExt:404011_2023-Artículo:258803
type: Generically Dependent Continuant
type: Anualidad
type: 2023
included: Unidad de Epidemiología de la Nutrición 2023
included: Salud Pública, Historia de la Ciencia y Ginecología 2023
type: Article
type: Entity
related by: AutorExt:404027_2023-Artículo:258803
date time value: 258803 pubdate
page start: 114561
most specific type: Academic Article
related by: Autor:5601-Artículo:258803
type: Information Content Entity
type: Academic Article
type: Continuant
page end: 114569
most specific type: 2023
has publication venue: BIOMEDICINE & PHARMACOTHERAPY
type: Thing
ARG_2000028: 258803 vcard

AutorExt:404028_2023-Artículo:258803
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Comparative effects of glucagon-like peptide-1 receptors agonists, 4-dipeptidyl peptidase inhibitors, and metformin on metabolic syndrome

AutorExt:404011_2023-Artículo:258803
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Comparative effects of glucagon-like peptide-1 receptors agonists, 4-dipeptidyl peptidase inhibitors, and metformin on metabolic syndrome

Unidad de Epidemiología de la Nutrición 2023
type: ResearchOrganizationReport
type: Anualidad
type: Thing
type: ResearchReport
type: 2023
includes: Comparative effects of glucagon-like peptide-1 receptors agonists, 4-dipeptidyl peptidase inhibitors, and metformin on metabolic syndrome

Salud Pública, Historia de la Ciencia y Ginecología 2023
type: Anualidad
type: DepartmentReport
type: Thing
type: ResearchReport
type: 2023
includes: Comparative effects of glucagon-like peptide-1 receptors agonists, 4-dipeptidyl peptidase inhibitors, and metformin on metabolic syndrome

AutorExt:404027_2023-Artículo:258803
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Comparative effects of glucagon-like peptide-1 receptors agonists, 4-dipeptidyl peptidase inhibitors, and metformin on metabolic syndrome

Autor:5601-Artículo:258803
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Comparative effects of glucagon-like peptide-1 receptors agonists, 4-dipeptidyl peptidase inhibitors, and metformin on metabolic syndrome

BIOMEDICINE & PHARMACOTHERAPY
type: Journal
publication venue for: Comparative effects of glucagon-like peptide-1 receptors agonists, 4-dipeptidyl peptidase inhibitors, and metformin on metabolic syndrome
type: Generically Dependent Continuant
type: Entity
type: Thing
type: Continuant
type: Information Content Entity
type: Collection
type: Periodical